Looking for:
What is the use of mometasone furoate cream usp.Mometasone Furoate Cream USP 0.1%MOMETASONE FUROATE: Uses, Side Effects and Medicines | Apollo Pharmacy - On this page
Mometasone Furoate Cream USP %.
What is the use of mometasone furoate cream usp
Avoid naked flames. If you need to use a dressing, like a bandage or plaster, wait at least 10 minutes after putting mometasone on. If you're treating a child, do not cover the cream or ointment with dressings or bandages. This can cause more medicine to pass through the skin and into the bloodstream, leading to a higher chance of side effects. If your doctor has prescribed it to treat very severe nappy rash, ask them how much to use and how long to use it for.
Once your skin starts getting better, do not stop using mometasone suddenly. Speak to your doctor, who might tell you to gradually reduce your dose or give you a milder steroid cream or ointment to use until you stop completely. Most people only need to use mometasone skin treatments for a short time.
Stop as soon as your skin is better. You will usually only use it for a few days. Children must not use mometasone skin treatments for more than 5 days, unless their doctor says to use it for longer. Only use the cream or ointment for longer than 5 days if your doctor tells you to. Speak to your doctor if your skin gets worse or does not get better within 14 days of using mometasone skin treatments. If you forget to use your mometasone, do not worry. In this case, skip the missed dose and apply the next one at the usual time.
Mometasone skin products are unlikely to cause any side effects if you follow the instructions. Some people get a burning or stinging feeling for a few minutes when they put mometasone on their skin. Ask your doctor if you need to carry a steroid emergency card. Serious side effects are rare.
Using mometasone for a long time can make your skin thinner or cause stretch marks. Stretch marks are likely to be permanent, but they usually fade over time. In very rare cases, using mometasone for a long time can slow down the normal growth of children and teenagers. Your child's doctor will monitor their height and weight carefully for as long as they're using this medicine.
This will help them to notice if your child's growth is being affected and change their treatment if needed. Even if your child's growth slows down, it does not seem to have much effect on their overall adult height. Talk to your doctor if you're worried. They will be able to explain the benefits and risks of your child using mometasone. It happens rarely but it is possible to have a serious allergic reaction anaphylaxis to mometasone.
These are not all the side effects of mometasone. For a full list see the leaflet inside your medicines packet. Mometasone skin treatments are not normally recommended if you're pregnant. Only use mometasone if your doctor or dermatologist skin specialist prescribes it and is supervising your treatment. They will be able to explain the benefits and risks of using mometasone. If you're using mometasone on your breasts, wash off any cream or ointment from your breasts, then wash your hands before feeding your baby.
It's usually better to use cream rather than ointment when breastfeeding, as it's easier to wash off. For more information about how mometasone for skin might affect you and your baby during pregnancy, read this leaflet about steroid creams and ointments on the Best Use of Medicines in Pregnancy BUMPs website. Other medicines are unlikely to affect the way mometasone skin treatments work.
There's very little information about taking herbal remedies and supplements while using mometasone. The following signs of skin atrophy were also observed among 97 patients treated with mometasone furoate cream USP 0. Striae were not observed in this study. The following additional local adverse reactions have been reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings.
These reactions are listed in an approximate decreasing order of occurrence: irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae, and miliaria.
Topically applied mometasone furoate cream USP 0. Apply a thin film of mometasone furoate cream USP 0. As with other corticosteroids, therapy should be discontinued when control is achieved.
If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP 0. Glenmark Generics Ltd. Tulsa, OK Pharmacokinetics: The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier.
Information for Patients: Patients using topical corticosteroids should receive the following information and instructions: This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes. This medication should not be used for any disorder other than that for which it was prescribed. The treated skin area should not be bandaged or otherwise covered or wrapped so as to be occlusive, unless directed by the physician.
Patients should report to their physician any signs of local adverse reactions. Parents of pediatric patients should be advised not to use mometasone furoate cream USP 0. This medication should not be used on the face, underarms, or groin areas unless directed by the physician. If no improvement is seen within 2 weeks, contact the physician.
Other corticosteroid-containing products should not be used with mometasone furoate cream USP 0. Carcinogenesis, Mutagenesis, Impairment of Fertility: Long-term animal studies have not been performed to evaluate the carcinogenic potential of mometasone furoate cream USP 0.
Call your doctor if your symptoms do not improve during this time. To use mometasone cream or ointment, apply a small amount of cream or ointment to cover the affected area of skin with a thin film.
To apply the lotion, place a few drops on the affected areas and massage lightly until it disappears. This medication is only for use on the skin. Do not let mometasone topical get into your eyes or mouth and do not swallow it. Avoid use on the face, in the genital and rectal areas, and in skin creases and armpits unless directed by your doctor. Do not wrap or bandage the treated area unless your doctor tells you that you should.
Such use may increase side effects. Do not use on a child's diaper area unless your doctor tells you that you should; do not use tight-fitting diapers or plastic pants. This medication may be prescribed for other uses; ask your doctor or pharmacist for more information. Apply the missed dose as soon as you remember it, However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not apply a double amount to make up for a missed dose.
Children who use mometasone topical may have an increased risk of side effects including slowed growth and delayed weight gain. Talk to your child's doctor about the risks of applying this medication to your child's skin. Mometasone topical may cause other side effects. Sexual Health Supplements. Feminine Hygiene. Women Supplements. Sexual Wellness. Health Concerns. Covid Test Kits. Pregnancy test Kit.
Weighing Machine. Health Accessories. Antiseptic Liquids. Cleaning Essentials. Personal Care. Mental Wellness. Face Mask. Steam Vaporizer. Multivitamins And Multiminerals. An allergic condition is an immune system response to a foreign substance allergens that is not typically harmful to your body, including certain foods, pollen, or pet dander.
It is used to treat redness and itching caused by certain skin conditions called psoriasis or dermatitis. Psoriasis is an autoimmune disorder that results in itchy and scaly rashes on the skin. Dermatitis is a generalised term for inflammation of the skin. It reduces the release of inflammatory mediators chemicals that cause inflammation.
When used as the topical form, it causes constriction of blood vessels decreasing the access of cells to the site of injury. This effect helps in reducing the swelling, pain, itching, and discomfort. However, if the side effects persist or worsen, please consult your doctor. It reduces inflammation, itchiness, and redness by preventing infection-fighting white blood cells WBCs from travelling to the affected area.
Back to Medicines A to Z. Mometasone skin treatments are used to treat itching, swollen and irritated skin. They can help with different types of eczema including atopic dermatitis and seborrheic dermatitis and psoriasis. Mometasone skin treatments are available on prescription only. They come as:. They are stronger than some other treatments. Mometasone is usually prescribed when milder steroids, like hydrocortisonehave not worked. Mometasone is a type of medicine known as a steroid also called a corticosteroid.
This is not the same as an anabolic steroid. Most adults and children aged 2 years and older can use mometasone skin treatments. Mometasone may not be suitable for some people. Tell a doctor or pharmacist before using it if you :. Always follow the instructions from a pharmacist, doctor or the leaflet that comes with your medicine.
Creams are better for skin that is moist and weepy. Ointments are thicker and greasier, and are better for dry or flaky areas of skin. The amount of cream or ointment you need to use is sometimes measured in fingertip units.
This is the amount you can squeeze onto the end of your finger. For children, the right amount of cream or ointment depends on their age. A doctor or pharmacist can advise you.
Skin creams can dry onto your clothes and bedding. This makes them more likely to catch fire. Avoid naked flames. If you need to use a dressing, like a bandage or plaster, wait at least 10 minutes after putting mometasone on. If you're treating a child, do not cover the cream or ointment with dressings or bandages. This can cause more medicine to pass through the skin and into the bloodstream, leading to a higher chance of side effects.
If your doctor has prescribed it to treat very severe nappy rash, ask them how much to use and how long to use it for. Once your skin starts getting better, do not stop using mometasone suddenly. Speak to your doctor, who might tell you to gradually reduce your dose or give you a milder steroid cream or ointment to use until you stop completely. Most people only need to use mometasone skin treatments for a short time.
Stop as soon as your skin is better. You will usually only use it for a few days. Children must not use mometasone skin treatments for more than 5 days, unless their doctor says to use it for longer.
Only use the cream or ointment for longer than 5 days if your doctor tells you to. Speak to your doctor if your skin gets worse or does not get better within 14 days of using mometasone skin treatments. If you forget to use your mometasone, do not worry. In this case, skip the missed dose and apply the next one at the usual time. Mometasone skin products are unlikely to cause any side effects if you follow the instructions. Some people get a burning or stinging feeling for a few minutes when they put mometasone on their skin.
Ask your doctor if you need to carry a steroid emergency card. Serious side effects are rare. Using mometasone for a long time can make your skin thinner or cause stretch marks. Stretch marks are likely to be permanent, but they usually fade over time.
In very rare cases, using mometasone for a long time can slow down the normal growth of children and teenagers. Your child's doctor will monitor their height and weight carefully for as long as they're using this medicine. This will help them to notice if your child's growth is being affected and change their treatment if needed. Even if your child's growth slows down, it does not seem to have much effect on their overall adult height.
Talk to your doctor if you're worried. They will be able to explain the benefits and risks of your child using mometasone. It happens rarely but it is possible to have a serious allergic reaction anaphylaxis to mometasone. These are not all the side effects of mometasone. For a full list see the leaflet inside your medicines packet. Mometasone skin treatments are not normally recommended if you're pregnant.
Only use mometasone if your doctor or dermatologist skin specialist prescribes it and is supervising your treatment. They will be able to explain the benefits and risks of using mometasone. If you're using mometasone on your breasts, wash off any cream or ointment from your breasts, then wash your hands before feeding your baby.
It's usually better to use cream rather than ointment when breastfeeding, as it's easier to wash off. For more information about how mometasone for skin might affect you and your baby during pregnancy, read this leaflet about steroid creams and ointments on the Best Use of Medicines in Pregnancy BUMPs website.
Other medicines are unlikely to affect the way mometasone skin treatments work. There's very little information about taking herbal remedies and supplements while using mometasone. Ask a pharmacist for advice. Tell your doctor or pharmacist if you're taking any other medicines, including herbal medicines, vitamins or supplements. Mometasone is a steroid also called a corticosteroid. Steroids help to reduce swelling inflammation in the skin and other parts of the body.
Skin gets inflamed when an allergic reaction or irritation causes chemicals to be released in the skin. These make your blood vessels widen and your irritated skin becomes red, swollen, itchy and painful.
This reduces any swelling, redness and itching. Speak to your doctor if there if your skin does not get better after 14 days, or if your skin gets worse at any time.
For long-term skin problems, such as eczema and psoriasis, you may need to use mometasone for 1 or 2 weeks, or sometimes for longer. Do not use mometasone on your face for more than 5 days, unless your doctor tells you this is OK. If your symptoms get worse or if they have not improved after 14 days after 5 days for a childask your doctor for further advice. Once your skin is better, you can use an emollient moisturising treatment to keep it from becoming inflamed again. If you need treatment for a long time, your doctor may decide you need to use a milder cream or ointment.
Talk to your doctor before stopping treatment if you've been using mometasone for a long time. They may tell you to gradually use less of it, and use it less often, before you stop completely. This reduces the chance of your symptoms coming back. Using mometasone for a long time without stopping can mean some of the medicine gets into your bloodstream. If you have been using mometasone for a long time, your doctor may tell you to gradually reduce the amount you use, or use a milder steroid, before stopping completely.
The skin on your face is delicate. If a doctor has said you can use it on your face, do not use it for more than 5 days. Steroids like mometasone reduce swelling inflammation in your skin to help manage your symptoms. They do not cure eczema. If you feel your symptoms are getting worse after using mometasone, it's important to tell a doctor. When you stop using mometasone, skin conditions like eczema and psoriasis can flare up again.
You can avoid this by gradually reducing the amount you put on, and how often you use it. Your doctor can tell you how to do this. But tell the doctor or nurse that you're using mometasone skin treatments so they can give the vaccine in an untreated area of your skin.
If you're using steroid medicines such as mometasone, your adrenal glands may not make as much of some of the hormones your body needs such as cortisol known as the stress hormone. This is known as adrenal insufficiency. This card is the size of a credit card and fits in your wallet or purse. If you need any medical or dental treatment, or are having surgery or an invasive procedure, show your steroid emergency card to your doctor or dentist.
This is important so they know you're having steroid treatment and can give you extra steroids as needed. However, speak to a pharmacist or your doctor if you are trying to get pregnant. Mometasone does not affect any type of contraception, including the combined pill and emergency contraception. Page last reviewed: 14 October Next review due: 14 October Mometasone for skin - Brand name: Elecon On this page About mometasone for skin Key facts Who can and cannot use mometasone for skin How and when to use mometasone for skin Side effects Pregnancy and breastfeeding Cautions with other medicines Common questions about mometasone for skin.
About mometasone for skin Mometasone skin treatments are used to treat itching, swollen and irritated skin. They come as: creams ointments scalp lotions They are stronger than some other treatments. It also comes as an inhaler and a nasal spray. Read about: mometasone inhalers — for asthma mometasone nasal sprays — for allergic rhinitis, hay fever and nasal polyps.
This medication is used to treat skin conditions such as eczema, psoriasis, allergies, and rash. Mometasone decreases swelling (inflammation), itching. Mometasone Furoate % w/w Cream is indicated for the treatment of inflammatory pruritic manifestations of and psoriasis (excluding widespread plaque psoriasis). Mometasone is a strong topical steroid medication that's used to treat certain skin conditions, like swelling, redness, itching, and skin irritation. It works by activating natural substances in the skin to reduce swelling, redness, and itching. How should this medicine be used? It is used to treat redness and itching caused by certain skin conditions called psoriasis or dermatitis. Psoriasis is an autoimmune disorder that results in. Can I drive or ride a bike?Mometasone furoate cream USP 0. Mometasone furoate is a synthetic corticosteroid with anti-inflammatory activity. Mometasone furoate is a white to off-white powder practically insoluble in water, slightly soluble in octanol, and moderately soluble in ethyl alcohol.
Each gram of mometasone furoate cream USP 0. Like other topical corticosteroids, mometasone furoate has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A 2 inhibitory proteins, collectively called lipocortins.
It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A 2. The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier. Occlusive dressings with hydrocortisone for up to 24 hours have not been demonstrated to increase penetration; however, occlusion of hydrocortisone for 96 hours markedly enhances penetration.
Studies in humans indicate that approximately 0. Studies performed with mometasone furoate cream USP 0. In a study evaluating the effects of mometasone furoate cream on the hypothalamic-pituitary-adrenal HPA axis, 15 grams were applied twice daily for 7 days to six adult patients with psoriasis or atopic dermatitis.
The results show that the drug caused a slight lowering of adrenal corticosteroid secretion. In a pediatric trial, 24 atopic dermatitis patients, of which 19 patients were age 2 to 12 years, were treated with mometasone furoate cream USP 0. The majority of patients cleared within 3 weeks.
Ninety-seven pediatric patients ages 6 to 23 months, with atopic dermatitis, were enrolled in an open-label, hypothalamic-pituitary-adrenal HPA axis safety study. Follow-up testing 2 to 4 weeks after stopping treatment, available for 5 of the patients, demonstrated suppressed HPA axis function in one patient, using these same criteria.
Since safety and efficacy of mometasone furoate cream USP 0. Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal HPA axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment. Patients applying a topical steroid to a large surface area or to areas under occlusion should be evaluated periodically for evidence of HPA axis suppression.
If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid.
Recovery of HPA axis function is generally prompt upon discontinuation of topical corticosteroids. Infrequently, signs and symptoms of glucocorticosteroid insufficiency may occur requiring supplemental systemic corticosteroids.
For information on systemic supplementation, see Prescribing Information for those products. If irritation develops, mometasone furoate cream USP 0. Allergic contact dermatitis with corticosteroids is usually diagnosed by observing a failure to heal rather than noting a clinical exacerbation as with most topical products not containing corticosteroids. Such an observation should be corroborated with appropriate diagnostic patch testing. If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used.
If a favorable response does not occur promptly, use of mometasone furoate cream USP 0. Patients using topical corticosteroids should receive the following information and instructions:.
The following tests may be helpful in evaluating patients for HPA axis suppression:. Long-term animal studies have not been performed to evaluate the carcinogenic potential of mometasone furoate cream USP 0. Long-term carcinogenicity studies of mometasone furoate were conducted by the inhalation route in rats and mice.
Mometasone furoate increased chromosomal aberrations in an in vitro Chinese hamster ovary cell assay, but did not increase chromosomal aberrations in an in vitro Chinese hamster lung cell assay. Mometasone furoate was not mutagenic in the Ames test or mouse lymphoma assay, and was not clastogenic in an in vivo mouse micronucleus assay, a rat bone marrow chromosomal aberration assay, or a mouse male germ-cell chromosomal aberration assay.
Mometasone furoate also did not induce unscheduled DNA synthesis in vivo in rat hepatocytes. Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels.
Some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. When administered to pregnant rats, rabbits, and mice, mometasone furoate increased fetal malformations. Mometasone furoate also caused dystocia and related complications when administered to rats during the end of pregnancy.
Similar effects were not observed at 7. Doses of 7. There are no adequate and well-controlled studies of teratogenic effects from topically applied corticosteroids in pregnant women. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects.
Because many drugs are excreted in human milk, caution should be exercised when mometasone furoate cream USP 0.
Use of mometasone furoate cream USP 0. Follow-up testing 2 to 4 weeks after study completion, available for 5 of the patients, demonstrated suppressed HPA axis function in one patient, using these same criteria. Pediatric patients may be more susceptible than adults to skin atrophy, including striae, when they are treated with topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels, and an absence of response to ACTH stimulation.
Manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. Clinical studies of mometasone furoate cream USP 0. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients. However, greater sensitivity of some older individuals cannot be ruled out.
In controlled clinical studies involving patients, the incidence of adverse reactions associated with the use of mometasone furoate cream USP 0. Reported reactions included burning, pruritus, and skin atrophy. Reports of rosacea associated with the use of mometasone furoate cream USP 0. Reported reactions included stinging, pruritus, and furunculosis. The following adverse reactions were reported to be possibly or probably related to treatment with mometasone furoate cream USP 0.
The following signs of skin atrophy were also observed among 97 patients treated with mometasone furoate cream USP 0. Striae were not observed in this study. The following additional local adverse reactions have been reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings.
These reactions are listed in an approximate decreasing order of occurrence: irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae, and miliaria. Topically applied mometasone furoate cream USP 0. Apply a thin film of mometasone furoate cream USP 0. As with other corticosteroids, therapy should be discontinued when control is achieved.
If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP 0. Glenmark Generics Ltd.
Tulsa, OK Pharmacokinetics: The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier.
Information for Patients: Patients using topical corticosteroids should receive the following information and instructions: This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes. This medication should not be used for any disorder other than that for which it was prescribed. The treated skin area should not be bandaged or otherwise covered or wrapped so as to be occlusive, unless directed by the physician.
Patients should report to their physician any signs of local adverse reactions. Parents of pediatric patients should be advised not to use mometasone furoate cream USP 0. This medication should not be used on the face, underarms, or groin areas unless directed by the physician. If no improvement is seen within 2 weeks, contact the physician. Other corticosteroid-containing products should not be used with mometasone furoate cream USP 0.
Carcinogenesis, Mutagenesis, Impairment of Fertility: Long-term animal studies have not been performed to evaluate the carcinogenic potential of mometasone furoate cream USP 0. Pregnancy: Teratogenic Effects: Pregnancy Category C: Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Nursing Mothers: Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects.
Manufactured: Glenmark Generics Ltd. Principal Display Panel. Product Information. Inactive Ingredients. Marketing Information. Labeler - Physicians Total Care, Inc.
No comments:
Post a Comment